Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole and Domperidone for GERD in Wheezy Infants
NCT02685436Phase 4Completed
- Sponsor
- Mansoura University Children Hospital
- Start
- Mar 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of omeprazole and domperidone in gastroesophageal reflux disease (GERD), sponsored by Mansoura University Children Hospital. Primary endpoint: Number of Participants in Each Level of Wheeze Control at 3 months. Started Mar 2013; status: completed.
02
Drugs
omeprazoledomperidone
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02685436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02685436.